Change in Haloperidol Level Due to Carbamazepine???A Complicating Factor in Combined Medication for Schizophrenia
- 1 February 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 10 (1) , 54-57
- https://doi.org/10.1097/00004714-199002000-00011
Abstract
Serum haloperidol levels were measured in patients who received haloperidol alone and, subsequently, haloperidol in combination with carbamazepine or lithium carbonate. Haloperidol levels and the level- dose ratios dropped about 50% in patients receiving carbamazepine. They remained the same in most patients receiving lithium carbonate. One patient receiving added carbamazepine experienced worsening of symptoms; this was associated with a drop in serum haloperidol level. Two other patients receiving added carbamazepine showed significant symptom reduction, although they also sustained drops in serum haloperidol levels. It is not clear whether these two individuals benefited from a primary antipsychotic effect of carbamazepine or from reduction of “toxic” haloperidol levels. Serum levels of antipsychotic medication should be monitored carefully when these medications are prescribed in combination with carbamazepine.This publication has 5 references indexed in Scilit:
- A carbamazepine trial in chronic, treatment-refractory schizophreniaAmerican Journal of Psychiatry, 1988
- Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesArchives of General Psychiatry, 1988
- REVIEW OF HALOPERIDOL BLOOD LEVEL AND CLINICAL-RESPONSE - LOOKING THROUGH THE WINDOW1987
- Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?American Journal of Psychiatry, 1986
- Relationship of serum haloperidol levels to clinical response in schizophrenic patientsAmerican Journal of Psychiatry, 1981